As of Dec 06
| -0.01 / -1.28%|
The 3 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +675.19% increase from the last price of 0.77.
The current consensus among 3 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.